{"id":"cetilistat","rwe":[{"pmid":"40040480","year":"2025","title":"Novel method to prevent severe postoperative pancreatic fistula caused by lipolysis.","finding":"","journal":"Journal of hepato-biliary-pancreatic sciences","studyType":"Clinical Study"},{"pmid":"38354494","year":"2024","title":"Pterostilbene alleviates cafeteria diet-induced obesity and underlying depression in adolescent male Swiss albino mice and affects insulin resistance, inflammation, HPA axis dysfunction and SIRT1 mediated leptin-ghrelin signaling.","finding":"","journal":"Hormones and behavior","studyType":"Clinical Study"},{"pmid":"38081381","year":"2024","title":"Pancreatic lipase and its related proteins: where are we now?","finding":"","journal":"Drug discovery today","studyType":"Clinical Study"},{"pmid":"36997571","year":"2023","title":"Metabolic profiling, antioxidant, and enzyme inhibition potential of Iris pseudacorus L. from Egypt and Japan: A comparative study.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"36510496","year":"2023","title":"Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective.","finding":"","journal":"Informatics in medicine unlocked","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Pancreatic triacylglycerol lipase","category":"target"},{"label":"PNLIP","category":"gene"},{"label":"Active","category":"status"},{"label":"Obesity","category":"indication"},{"label":"Anti-Obesity Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Lipid Regulating Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CETILISTAT","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:20.018507+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:28.177550+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CETILISTAT","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:28.544689+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Gastric lipase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:29.587920+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103825/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:29.246878+00:00"}},"allNames":"oblean","offLabel":[],"synonyms":["cetilistat","ATL-962","oblean"],"timeline":[{"date":"2013-09-20","type":"positive","source":"DrugCentral","milestone":"PMDA approval"}],"approvals":[{"date":"2013-09-20","orphan":false,"company":"","regulator":"PMDA"}],"brandName":"Oblean","ecosystem":[{"indication":"Obesity","otherDrugs":[{"name":"amfetamine","slug":"amfetamine","company":"Ucb Inc"},{"name":"benzphetamine","slug":"benzphetamine","company":"Pharmacia And Upjohn"},{"name":"bupropion","slug":"bupropion","company":"Glaxosmithkline"},{"name":"chlorphentermine","slug":"chlorphentermine","company":"Parke Davis"}],"globalPrevalence":890000000}],"mechanism":{"target":"Pancreatic triacylglycerol lipase","targets":[{"gene":"PNLIP","source":"DrugCentral","target":"Pancreatic triacylglycerol lipase","protein":"Pancreatic triacylglycerol lipase"}],"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Oblean specifically inhibits the activity of pancreatic triacylglycerol lipase, a key enzyme involved in the digestion and absorption of dietary fats. By blocking this enzyme, Oblean reduces the breakdown of triacylglycerols into free fatty acids and glycerol, thereby decreasing the absorption of dietary fats."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4886","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CETILISTAT","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CETILISTAT","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:31:59.052074","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:30.909408+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"cetilistat","indications":{"approved":[{"name":"Obesity","source":"DrugCentral","snomedId":414916001,"regulator":"FDA","usPrevalence":100000000,"globalPrevalence":890000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2024"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00148382","phase":"PHASE1","title":"Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects","status":"COMPLETED","sponsor":"Alizyme","startDate":"2005-04","conditions":["Obesity"],"enrollment":80,"completionDate":"2005-07"},{"nctId":"NCT00156897","phase":"PHASE2","title":"Efficacy and Safety of ATL-962 in Obese Diabetics","status":"COMPLETED","sponsor":"Alizyme","startDate":"2004-12","conditions":["Non-Insulin-Dependent Diabetes Mellitus","Obesity"],"enrollment":600,"completionDate":"2005-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"LC5G1JUA39","CHEBI":"CHEBI:134721","INN_ID":"8461","UMLSCUI":"C1957370","chemblId":"CHEMBL2103825","ChEMBL_ID":"CHEMBL2103825","KEGG_DRUG":"D09208","DRUGBANK_ID":"DB06586","PUBCHEM_CID":"9952916","IUPHAR_LIGAND_ID":"11433","MESH_SUPPLEMENTAL_RECORD_UI":"C520092"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":27,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"recentPublications":[{"date":"2025 Jun","pmid":"40040480","title":"Novel method to prevent severe postoperative pancreatic fistula caused by lipolysis.","journal":"Journal of hepato-biliary-pancreatic sciences"},{"date":"2024 May","pmid":"38354494","title":"Pterostilbene alleviates cafeteria diet-induced obesity and underlying depression in adolescent male Swiss albino mice and affects insulin resistance, inflammation, HPA axis dysfunction and SIRT1 mediated leptin-ghrelin signaling.","journal":"Hormones and behavior"},{"date":"2024 Jan","pmid":"38081381","title":"Pancreatic lipase and its related proteins: where are we now?","journal":"Drug discovery today"},{"date":"2023 Mar 30","pmid":"36997571","title":"Metabolic profiling, antioxidant, and enzyme inhibition potential of Iris pseudacorus L. from Egypt and Japan: A comparative study.","journal":"Scientific reports"},{"date":"2023","pmid":"36510496","title":"Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective.","journal":"Informatics in medicine unlocked"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oblean, also known as cetilistat, is a small molecule inhibitor that targets pancreatic triacylglycerol lipase. It works by inhibiting pancreatic lipase, a mechanism that is used to treat obesity.","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2013-09-20T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:30.909408+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}